{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T06:07:47Z","timestamp":1789193267714,"version":"build-2803163510"},"reference-count":31,"publisher":"BMJ","issue":"9","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"unspecified","delay-in-days":10,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2020-06135"],"award-info":[{"award-number":["2020-06135"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2023-06395"],"award-info":[{"award-number":["2023-06395"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2025-00188"],"award-info":[{"award-number":["2025-00188"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"name":"ALF Grants, Region \u00d6sterg\u00f6tland","award":["R\u00d6-972826"],"award-info":[{"award-number":["R\u00d6-972826"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,7,15]]},"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Studies have shown promising results using bone graft as a carrier for local administration of antibiotics to reduce the risk of prosthetic joint infection (PJI). The objective of this clinical trial is to determine if tobramycin and vancomycin-impregnated bone graft is safe and effective in reducing the rate of PJI after total hip arthroplasty (THA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>This study is an international, randomised, double-blinded, placebo-controlled clinical drug trial. Patients scheduled for THA (n=1100) requiring bone grafting (excluding revisions due to an ongoing infection) are randomised in a 1:1 ratio to prophylactic treatment with tobramycin and vancomycin or placebo-impregnated bone graft.<\/jats:p>\n                    <jats:p>The primary outcome is the time to reoperation due to infection or diagnosis of PJI, expressed as a relative risk difference between the two groups. A risk reduction of at least 50% is considered clinically relevant. Secondary outcomes are time to and reason for reoperation and implant revision, type of micro-organism and antibiotic susceptibility pattern within 2 and 5 years after surgery. Safety outcomes are the number of adverse events and revision rate due to aseptic loosening. The primary analysis will be performed using proportional hazard models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>The study has been approved under the Clinical Trial Regulation No 536\/2014 (EU CT; 2024-510921-25-00). Results will be published in open-access peer-reviewed journals and disseminated to patient organisations and the media, and de-identified individual participant data will be curated and shared on reasonable request in accordance with the Findability, Accessibility, Interoperability and Reuse principles, subject to the laws and regulations governing data protection in each participating country.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT05169229\">NCT05169229<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2025-114161","type":"journal-article","created":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T05:15:22Z","timestamp":1789190122000},"page":"e114161","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Antibiotic-impregnated bone graft to prevent infection after total hip arthroplasty (ABOGRAFT): protocol for a randomised, double-blind, placebo-controlled trial"],"prefix":"10.1136","volume":"16","clinical-trial-number":[{"clinical-trial-number":"nct05169229","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct05169229","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0760-8997","authenticated-orcid":false,"given":"Daphne","family":"Wezenberg","sequence":"first","affiliation":[{"name":"Department of Biomedical and Clinical Sciences, Link\u00f6ping University, Link\u00f6ping, Sweden"},{"name":"Clinical Department of Orthopaedics, Region \u00d6sterg\u00f6tland, Link\u00f6ping, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils P","family":"Hailer","sequence":"additional","affiliation":[{"name":"Department of Surgical Sciences\/Orthopedics, Uppsala University, Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olof","family":"Sk\u00f6ldenberg","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Danderyd Hospital, Division of Orthopedics, Karolinska Institute, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Stef\u00e1nsd\u00f3ttir","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Division of Orthopedics, Department of Orthopedics, Lund University, Sk\u00e5ne University Hospital, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9255-075X","authenticated-orcid":false,"given":"Georgios","family":"Tsikandylakis","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7840-8979","authenticated-orcid":false,"given":"Peter","family":"Wildeman","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, Faculty of Medicine and Health, \u00d6rebro Universitet, \u00d6rebro, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"K\u00e4rrholm","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"S\u00f6derquist","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, Faculty of Medicine and Health, \u00d6rebro Universitet, \u00d6rebro, Sweden"},{"name":"School of Medical Sciences, Faculty of Medicine and Health, \u00d6rebro University, \u00d6rebro, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lennart E","family":"Nilsson","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Clinical Sciences, Link\u00f6ping University, Link\u00f6ping, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Schilcher","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Clinical Sciences, Link\u00f6ping University, Link\u00f6ping, Sweden"},{"name":"Clinical Department of Orthopaedics, Region \u00d6sterg\u00f6tland, Link\u00f6ping, Sweden"},{"name":"Wallenberg Centre for Molecular Medicine, Link\u00f6ping University, Link\u00f6ping, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"key":"2026091122151543000_16.9.e114161.1","doi-asserted-by":"publisher","DOI":"10.1097\/CORR.0000000000001838"},{"key":"2026091122151543000_16.9.e114161.2","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ocl.2023.09.002","article-title":"Recurrent Periprosthetic Joint Infections: Diagnosis, Management, and Outcomes","volume":"55","author":"Deans","year":"2024","journal-title":"Orthop Clin North Am"},{"key":"2026091122151543000_16.9.e114161.3","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ocl.2023.09.001","article-title":"Current Concepts on the Clinical and Economic Impact of Periprosthetic Joint Infections","volume":"55","author":"Sadhwani","year":"2024","journal-title":"Orthop Clin North Am"},{"key":"2026091122151543000_16.9.e114161.4","doi-asserted-by":"crossref","DOI":"10.1186\/s13018-023-04060-5","article-title":"Incidence of periprosthetic joint infection after primary total hip arthroplasty is underestimated: a synthesis of meta-analysis and bibliometric analysis","volume":"18","author":"Zeng","year":"2023","journal-title":"J Orthop Surg Res"},{"key":"2026091122151543000_16.9.e114161.5","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-076576","article-title":"Effect of a national infection control programme in Sweden on prosthetic joint infection incidence following primary total hip arthroplasty: a cohort study","volume":"14","author":"Wildeman","year":"2024","journal-title":"BMJ Open"},{"key":"2026091122151543000_16.9.e114161.6","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1016\/j.arth.2017.01.037","article-title":"Complications After Revision Total Hip Arthroplasty in the Medicare Population","volume":"32","author":"Badarudeen","year":"2017","journal-title":"J Arthroplasty"},{"key":"2026091122151543000_16.9.e114161.7","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/17453674.2019.1708655","article-title":"Outcome of revision hip arthroplasty in patients younger than 55 years: an analysis of 1,037 revisions in the Dutch Arthroplasty Register","volume":"91","author":"Kuijpers","year":"2020","journal-title":"Acta Orthop"},{"key":"2026091122151543000_16.9.e114161.8","doi-asserted-by":"crossref","first-page":"52","DOI":"10.7150\/jbji.17466","article-title":"Allograft Bone as Antibiotic Carrier","volume":"2","author":"Winkler","year":"2017","journal-title":"J Bone Jt Infect"},{"key":"2026091122151543000_16.9.e114161.9","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1016\/j.arth.2019.04.043","article-title":"The Economics of Antibiotic Cement in Total Knee Arthroplasty: Added Cost with No Reduction in Infection Rates","volume":"34","author":"Yayac","year":"2019","journal-title":"J Arthroplasty"},{"key":"2026091122151543000_16.9.e114161.10","doi-asserted-by":"crossref","DOI":"10.1186\/s12891-017-1737-4","article-title":"Elution kinetics of vancomycin and gentamicin from carriers and their effects on mesenchymal stem cell proliferation: an in vitro study","volume":"18","author":"Kucera","year":"2017","journal-title":"BMC Musculoskelet Disord"},{"key":"2026091122151543000_16.9.e114161.11","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1302\/2058-5241.4.180104","article-title":"Risk assessment of antibiotic resistance development by antibiotic-loaded bone cements: is it a clinical concern?","volume":"4","author":"Berberich","year":"2019","journal-title":"EFORT Open Rev"},{"key":"2026091122151543000_16.9.e114161.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2010.05.005"},{"key":"2026091122151543000_16.9.e114161.13","doi-asserted-by":"publisher","DOI":"10.1016\/S0883-5403(98)90179-6"},{"key":"2026091122151543000_16.9.e114161.14","doi-asserted-by":"crossref","first-page":"245","DOI":"10.7150\/jbji.38373","article-title":"Current Insights in the Application of Bone Grafts for Local Antibiotic Delivery in Bone Reconstruction Surgery","volume":"4","author":"Peeters","year":"2019","journal-title":"J Bone Jt Infect"},{"key":"2026091122151543000_16.9.e114161.15","doi-asserted-by":"crossref","first-page":"S229","DOI":"10.1016\/j.arth.2024.03.069","article-title":"Safety Profile of Seven-Day Intra-articular Antibiotic Irrigation for the Treatment of Chronic Periprosthetic Joint Infection: A Prospective Randomized Phase II Comparative Study","volume":"39","author":"Springer","year":"2024","journal-title":"J Arthroplasty"},{"key":"2026091122151543000_16.9.e114161.16","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/538061","article-title":"Antibiotic-impregnated bone grafts in orthopaedic and trauma surgery: a systematic review of the literature","volume":"2012","author":"Anagnostakos","year":"2012","journal-title":"Int J Biomater"},{"key":"2026091122151543000_16.9.e114161.17","doi-asserted-by":"crossref","unstructured":"Hr\u00f3bjartsson A , Boutron I , Hopewell S , et al . SPIRIT 2025 explanation and elaboration: updated guideline for protocols of randomised trials. BMJ 2025;389. doi:10.1136\/bmj-2024-081660","DOI":"10.1136\/bmj-2024-081660"},{"key":"2026091122151543000_16.9.e114161.18","doi-asserted-by":"crossref","unstructured":"Berglund B , Wezenberg D , Nilsson M , et al . Bone allograft impregnated with tobramycin and vancomycin delivers antibiotics in high concentrations for prophylaxis against bacteria commonly associated with prosthetic joint infections. Microbiol Spectr 2024;12. doi:10.1128\/spectrum.00414-24","DOI":"10.1128\/spectrum.00414-24"},{"key":"2026091122151543000_16.9.e114161.19","unstructured":"R: a language and environment for statistical computing [program]. Vienna, Austria R Foundation for Statistical Computing; 2024."},{"key":"2026091122151543000_16.9.e114161.20","doi-asserted-by":"publisher","DOI":"10.1302\/0301-620X.103B1.BJJ-2020-1381.R1"},{"key":"2026091122151543000_16.9.e114161.21","unstructured":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) . Guideline for good clinical practice E6(R3) 2025. 2025. Available: https:\/\/database.ich.org\/sites\/default\/files\/ICH_E6%28R3%29_Step4_FinalGuideline_2025_0106.pdf [Accessed 9 May 2025]."},{"key":"2026091122151543000_16.9.e114161.22","first-page":"1","article-title":"Revision Surgery in Total Joint Replacement Is Cost-Intensive","volume":"2018","author":"Weber","year":"2018","journal-title":"Biomed Res Int"},{"key":"2026091122151543000_16.9.e114161.23","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1016\/j.arth.2020.04.085","article-title":"Total Hip Arthroplasty After Prior Acetabular Fracture: Infection Is a Real Concern","volume":"35","author":"Aali Rezaie","year":"2020","journal-title":"J Arthroplasty"},{"key":"2026091122151543000_16.9.e114161.24","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2147\/CLEP.S347968","article-title":"Prediction of Early Periprosthetic Joint Infection After Total Hip Arthroplasty","volume":"14","author":"B\u00fclow","year":"2022","journal-title":"Clin Epidemiol"},{"key":"2026091122151543000_16.9.e114161.25","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s00402-021-04190-7","article-title":"Reinfection rates after one- and two-stage revision surgery for hip and knee arthroplasty: a systematic review and meta-analysis","volume":"143","author":"Goud","year":"2023","journal-title":"Arch Orthop Trauma Surg"},{"key":"2026091122151543000_16.9.e114161.26","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1302\/0301-620X.106B6.BJJ-2023-1181.R1","article-title":"Re-revision and mortality rate following revision total hip arthroplasty for infection","volume":"106-B","author":"Resl","year":"2024","journal-title":"Bone Joint J"},{"key":"2026091122151543000_16.9.e114161.27","unstructured":"Swedish Arthroplasty Register . Annual report 2024 (data over 2023). G\u00f6teborg Swedish Arthroplasty Register; 2024. doi:10.18158\/i_2vVZosV"},{"key":"2026091122151543000_16.9.e114161.28","doi-asserted-by":"crossref","DOI":"10.1016\/j.artd.2024.101333","article-title":"Intra-articular Vancomycin Reduces Prosthetic Infection in Primary Hip and Knee Arthroplasty","volume":"26","author":"Burns","year":"2024","journal-title":"Arthroplast Today"},{"key":"2026091122151543000_16.9.e114161.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2023.04.005"},{"key":"2026091122151543000_16.9.e114161.30","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics12071654","article-title":"Microbiological Profiles of Patients with Periprosthetic Joint Infection of the Hip or Knee","volume":"12","author":"Fr\u00f6schen","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"2026091122151543000_16.9.e114161.31","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c869","article-title":"CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Moher","year":"2010","journal-title":"BMJ"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-114161","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T05:15:27Z","timestamp":1789190127000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-114161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":31,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9,11]]},"published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1136\/bmjopen-2025-114161"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-114161","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]}}}